BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 12653965)

  • 1. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles.
    Itoh K; Wakabayashi N; Katoh Y; Ishii T; O'Connor T; Yamamoto M
    Genes Cells; 2003 Apr; 8(4):379-91. PubMed ID: 12653965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression.
    McMahon M; Itoh K; Yamamoto M; Hayes JD
    J Biol Chem; 2003 Jun; 278(24):21592-600. PubMed ID: 12682069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism.
    Velichkova M; Hasson T
    Mol Cell Biol; 2005 Jun; 25(11):4501-13. PubMed ID: 15899855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles.
    Itoh K; Tong KI; Yamamoto M
    Free Radic Biol Med; 2004 May; 36(10):1208-13. PubMed ID: 15110385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1.
    Nguyen T; Sherratt PJ; Nioi P; Yang CS; Pickett CB
    J Biol Chem; 2005 Sep; 280(37):32485-92. PubMed ID: 16000310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes.
    Kang MI; Kobayashi A; Wakabayashi N; Kim SG; Yamamoto M
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2046-51. PubMed ID: 14764898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome.
    Katoh Y; Iida K; Kang MI; Kobayashi A; Mizukami M; Tong KI; McMahon M; Hayes JD; Itoh K; Yamamoto M
    Arch Biochem Biophys; 2005 Jan; 433(2):342-50. PubMed ID: 15581590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm.
    Zipper LM; Mulcahy RT
    J Biol Chem; 2002 Sep; 277(39):36544-52. PubMed ID: 12145307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.
    Kobayashi A; Kang MI; Okawa H; Ohtsuji M; Zenke Y; Chiba T; Igarashi K; Yamamoto M
    Mol Cell Biol; 2004 Aug; 24(16):7130-9. PubMed ID: 15282312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.
    Wakabayashi N; Dinkova-Kostova AT; Holtzclaw WD; Kang MI; Kobayashi A; Yamamoto M; Kensler TW; Talalay P
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2040-5. PubMed ID: 14764894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers.
    Kwak MK; Wakabayashi N; Kensler TW
    Mutat Res; 2004 Nov; 555(1-2):133-48. PubMed ID: 15476857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.
    Kwak MK; Wakabayashi N; Itoh K; Motohashi H; Yamamoto M; Kensler TW
    J Biol Chem; 2003 Mar; 278(10):8135-45. PubMed ID: 12506115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway.
    Kwak MK; Wakabayashi N; Greenlaw JL; Yamamoto M; Kensler TW
    Mol Cell Biol; 2003 Dec; 23(23):8786-94. PubMed ID: 14612418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation.
    Wakabayashi N; Itoh K; Wakabayashi J; Motohashi H; Noda S; Takahashi S; Imakado S; Kotsuji T; Otsuka F; Roop DR; Harada T; Engel JD; Yamamoto M
    Nat Genet; 2003 Nov; 35(3):238-45. PubMed ID: 14517554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.
    Zhang DD; Hannink M
    Mol Cell Biol; 2003 Nov; 23(22):8137-51. PubMed ID: 14585973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants.
    Dinkova-Kostova AT; Holtzclaw WD; Cole RN; Itoh K; Wakabayashi N; Katoh Y; Yamamoto M; Talalay P
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11908-13. PubMed ID: 12193649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase.
    Cullinan SB; Gordan JD; Jin J; Harper JW; Diehl JA
    Mol Cell Biol; 2004 Oct; 24(19):8477-86. PubMed ID: 15367669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet A irradiation induces NF-E2-related factor 2 activation in dermal fibroblasts: protective role in UVA-induced apoptosis.
    Hirota A; Kawachi Y; Itoh K; Nakamura Y; Xu X; Banno T; Takahashi T; Yamamoto M; Otsuka F
    J Invest Dermatol; 2005 Apr; 124(4):825-32. PubMed ID: 15816842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.
    Eggler AL; Liu G; Pezzuto JM; van Breemen RB; Mesecar AD
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10070-5. PubMed ID: 16006525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.